• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤治疗中程序性细胞死亡研究的进展:全面综述

Advancements in programmed cell death research in antitumor therapy: a comprehensive overview.

作者信息

Wei Shuxin, Han Chuangye, Mo Shutian, Huang Hailian, Luo Xiaoling

机构信息

School of Basic Medical Sciences, Guangxi Medical University, Nanning, 530021, China.

Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, 530021, China.

出版信息

Apoptosis. 2025 Feb;30(1-2):401-421. doi: 10.1007/s10495-024-02038-0. Epub 2024 Nov 2.

DOI:10.1007/s10495-024-02038-0
PMID:39487314
Abstract

Cell death is a normal physiological process within cells that involves multiple pathways, such as normal DNA damage, cell cycle arrest, and programmed cell death (PCD). Cell death has been a hot spot of research in tumor-related fields, especially programmed cell death, which is a key form of cell death and is classified into different types according to the mechanism of occurrence, such as apoptosis, autophagy, necroptosis, pyroptosis, ferroptosis, and disulfidptosis. Given the important role of PCD in maintaining tissue homeostasis and inhibiting tumorigenesis and development, more and more basic and clinical studies are devoted to revealing its potential application in anti-tumor strategies. The purpose of this review is to systematically review the regulatory mechanisms of PCD and to summarize the latest research progress of anti-tumor treatment strategies based on PCD.

摘要

细胞死亡是细胞内的一种正常生理过程,涉及多种途径,如正常的DNA损伤、细胞周期停滞和程序性细胞死亡(PCD)。细胞死亡一直是肿瘤相关领域的研究热点,尤其是程序性细胞死亡,它是细胞死亡的一种关键形式,并根据发生机制分为不同类型,如凋亡、自噬、坏死性凋亡、焦亡、铁死亡和二硫键介导的细胞死亡。鉴于程序性细胞死亡在维持组织稳态以及抑制肿瘤发生和发展中的重要作用,越来越多的基础和临床研究致力于揭示其在抗肿瘤策略中的潜在应用。本综述的目的是系统地综述程序性细胞死亡的调控机制,并总结基于程序性细胞死亡的抗肿瘤治疗策略的最新研究进展。

相似文献

1
Advancements in programmed cell death research in antitumor therapy: a comprehensive overview.肿瘤治疗中程序性细胞死亡研究的进展:全面综述
Apoptosis. 2025 Feb;30(1-2):401-421. doi: 10.1007/s10495-024-02038-0. Epub 2024 Nov 2.
2
Potential value and cardiovascular risks of programmed cell death in cancer treatment.程序性细胞死亡在癌症治疗中的潜在价值与心血管风险
Front Pharmacol. 2025 Jul 3;16:1615974. doi: 10.3389/fphar.2025.1615974. eCollection 2025.
3
Targeting Programmed Cell Death as an Innovative Strategy Against Atherosclerosis: Potential of Natural Compound Supplements.将程序性细胞死亡作为抗动脉粥样硬化的创新策略:天然化合物补充剂的潜力
Phytother Res. 2025 Aug;39(8):3664-3708. doi: 10.1002/ptr.70027. Epub 2025 Jul 9.
4
PANoptosis: a potential new target for programmed cell death in breast cancer treatment and prognosis.PANoptosis:乳腺癌治疗和预后中程序性细胞死亡的潜在新靶点。
Apoptosis. 2024 Apr;29(3-4):277-288. doi: 10.1007/s10495-023-01904-7. Epub 2023 Nov 24.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.基于 13 种程序性细胞死亡模式的机器学习对肺腺癌患者预后和治疗反应预测的分子亚型。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11351-11368. doi: 10.1007/s00432-023-05000-w. Epub 2023 Jun 28.
7
Microglia programmed cell death in neurodegenerative diseases and CNS injury.神经退行性疾病和中枢神经系统损伤中的小胶质细胞程序性细胞死亡。
Apoptosis. 2025 Feb;30(1-2):446-465. doi: 10.1007/s10495-024-02041-5. Epub 2024 Dec 10.
8
Regulated programmed cell death in acute lung injury: from pathogenesis to therapy.急性肺损伤中程序性细胞死亡的调控:从发病机制到治疗
Front Immunol. 2025 Jul 23;16:1630015. doi: 10.3389/fimmu.2025.1630015. eCollection 2025.
9
Programmed cell death: A pivotal player in pulmonary arterial hypertension.程序性细胞死亡:肺动脉高压中的关键角色。
Eur J Pharmacol. 2025 Sep 15;1003:177934. doi: 10.1016/j.ejphar.2025.177934. Epub 2025 Jul 8.
10
Machine learning-based analysis of programmed cell death types and key genes in intervertebral disc degeneration.基于机器学习的椎间盘退变中程序性细胞死亡类型及关键基因分析
Apoptosis. 2025 Feb;30(1-2):250-266. doi: 10.1007/s10495-024-02047-z. Epub 2024 Dec 4.

引用本文的文献

1
Emerging roles of tsRNAs in programmed cell death and disease therapeutics: challenges, opportunities, and future directions.tsRNAs在程序性细胞死亡和疾病治疗中的新作用:挑战、机遇与未来方向
Noncoding RNA Res. 2025 Jul 11;15:65-73. doi: 10.1016/j.ncrna.2025.07.003. eCollection 2025 Dec.
2
Mechanistic Insights into Autophagy-Dependent Cell Death (ADCD): A Novel Avenue for Cancer Therapy.自噬依赖性细胞死亡(ADCD)的机制性见解:癌症治疗的新途径。
Cells. 2025 Jul 13;14(14):1072. doi: 10.3390/cells14141072.
3
Identification of programmed cell death-related genes and construction of a prognostic model in oral squamous cell carcinoma using single-cell and transcriptome analysis.

本文引用的文献

1
Circulating tumor DNA predicts venous thromboembolism in patients with cancers.循环肿瘤DNA可预测癌症患者的静脉血栓栓塞。
J Thromb Haemost. 2025 Jan;23(1):139-148. doi: 10.1016/j.jtha.2024.09.009. Epub 2024 Sep 26.
2
Copper Chelation Therapy Attenuates Periodontitis Inflammation through the Cuproptosis/Autophagy/Lysosome Axis.铜螯合疗法通过铜死亡/自噬/溶酶体轴减轻牙周炎炎症。
Int J Mol Sci. 2024 May 28;25(11):5890. doi: 10.3390/ijms25115890.
3
Selenium reduction of ubiquinone via SQOR suppresses ferroptosis.硒通过 SQOR 将泛醌还原从而抑制铁死亡。
利用单细胞和转录组分析鉴定口腔鳞状细胞癌中程序性细胞死亡相关基因并构建预后模型
Discov Oncol. 2025 May 9;16(1):713. doi: 10.1007/s12672-025-02520-4.
4
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer.癌症中克服化疗耐药性的分子机制与治疗策略
Mol Biomed. 2025 Jan 6;6(1):2. doi: 10.1186/s43556-024-00239-2.
Nat Metab. 2024 Feb;6(2):343-358. doi: 10.1038/s42255-024-00974-4. Epub 2024 Feb 13.
4
Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review.阿那白滞素和卡那奴单抗在 PSTPIP1 相关炎症性疾病中的疗效和安全性:全面的范围综述。
Front Immunol. 2024 Jan 8;14:1339337. doi: 10.3389/fimmu.2023.1339337. eCollection 2023.
5
MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease.MCC950通过抑制阿尔茨海默病大鼠模型中依赖NLRP3的神经炎症来减少自噬并改善认知功能。
Brain Behav Immun. 2024 Feb;116:70-84. doi: 10.1016/j.bbi.2023.11.031. Epub 2023 Nov 29.
6
Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development.实现 Project Optimus 的承诺:肿瘤药物开发中剂量优化的挑战和新兴机遇。
CPT Pharmacometrics Syst Pharmacol. 2024 May;13(5):691-709. doi: 10.1002/psp4.13079. Epub 2024 Mar 21.
7
FDX1 Is Required for the Biogenesis of Mitochondrial Cytochrome c Oxidase in Mammalian Cells.FDX1 对于哺乳动物细胞中线粒体细胞色素 c 氧化酶的生物发生是必需的。
J Mol Biol. 2023 Dec 1;435(23):168317. doi: 10.1016/j.jmb.2023.168317. Epub 2023 Oct 17.
8
Resveratrol reduces ROS-induced ferroptosis by activating SIRT3 and compensating the GSH/GPX4 pathway.白藜芦醇通过激活 SIRT3 和补偿 GSH/GPX4 通路来减少 ROS 诱导的铁死亡。
Mol Med. 2023 Oct 19;29(1):137. doi: 10.1186/s10020-023-00730-6.
9
Zα domain proteins mediate the immune response.Zα 结构域蛋白介导免疫反应。
Front Immunol. 2023 Sep 12;14:1241694. doi: 10.3389/fimmu.2023.1241694. eCollection 2023.
10
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.CBFA2T3::GLIS2 小儿急性巨核细胞白血病对 navitoclax 和 DT2216 抑制 BCL-XL 敏感。
Blood Adv. 2024 Jan 9;8(1):112-129. doi: 10.1182/bloodadvances.2022008899.